ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 59 filers reported holding ODONATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,302,000 | -53.5% | 964,818 | +0.3% | 0.00% | – |
Q3 2021 | $2,800,000 | -17.2% | 962,199 | -0.7% | 0.00% | – |
Q2 2021 | $3,381,000 | +3.1% | 968,687 | +1.1% | 0.00% | – |
Q1 2021 | $3,278,000 | -82.4% | 958,587 | -1.0% | 0.00% | -100.0% |
Q4 2020 | $18,599,000 | +79.8% | 968,707 | +25.8% | 0.00% | – |
Q3 2020 | $10,343,000 | -64.2% | 770,171 | +12.9% | 0.00% | -100.0% |
Q2 2020 | $28,878,000 | +57.0% | 682,071 | +2.4% | 0.00% | 0.0% |
Q1 2020 | $18,397,000 | -16.0% | 666,339 | -1.3% | 0.00% | 0.0% |
Q4 2019 | $21,907,000 | +25.1% | 675,094 | +0.4% | 0.00% | 0.0% |
Q3 2019 | $17,510,000 | +6.7% | 672,675 | +50.3% | 0.00% | 0.0% |
Q2 2019 | $16,416,000 | +104.9% | 447,411 | +23.5% | 0.00% | – |
Q1 2019 | $8,010,000 | +160.7% | 362,278 | +66.1% | 0.00% | – |
Q4 2018 | $3,072,000 | -50.0% | 218,130 | -31.1% | 0.00% | – |
Q3 2018 | $6,148,000 | +4.2% | 316,733 | +18.5% | 0.00% | – |
Q2 2018 | $5,899,000 | +12.7% | 267,205 | +8.1% | 0.00% | – |
Q1 2018 | $5,235,000 | +246.5% | 247,197 | +309.1% | 0.00% | – |
Q4 2017 | $1,511,000 | – | 60,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 14,075,269 | $595,947,000 | 57.94% |
Samsara BioCapital, LLC | 496,505 | $21,022,000 | 6.76% |
Boxer Capital, LLC | 3,363,377 | $142,405,000 | 6.26% |
Opaleye Management Inc. | 250,000 | $10,585,000 | 2.14% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 785,913 | $33,276,000 | 0.81% |
RTW INVESTMENTS, LP | 481,027 | $20,367,000 | 0.57% |
Birchview Capital, LP | 20,000 | $847,000 | 0.51% |
Rock Springs Capital Management LP | 437,231 | $18,512,000 | 0.51% |
Redmile Group, LLC | 633,038 | $26,803,000 | 0.50% |
SABBY MANAGEMENT, LLC | 40,500 | $1,715,000 | 0.34% |